Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 861

Similar articles for PubMed (Select 9048844)

1.

Paralytic poliomyelitis--United States, 1980-1994.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1997 Jan 31;46(4):79-83.

3.

Poliomyelitis prevention in the United States. Updated recommendations of the Advisory Committee on Immunization Practices (ACIP).

Prevots DR, Burr RK, Sutter RW, Murphy TV; Advisory Committee on Immunization Practices.

MMWR Recomm Rep. 2000 May 9;49(RR-5):1-22; quiz CE1-7.

4.
6.

Vaccine policy changes and epidemiology of poliomyelitis in the United States.

Alexander LN, Seward JF, Santibanez TA, Pallansch MA, Kew OM, Prevots DR, Strebel PM, Cono J, Wharton M, Orenstein WA, Sutter RW.

JAMA. 2004 Oct 13;292(14):1696-701.

PMID:
15479934
8.

Impact of the sequential IPV/OPV schedule on vaccination coverage levels--United States, 1997.

Centers for Disease Control and Prevention (CDC).

MMWR Morb Mortal Wkly Rep. 1998 Dec 4;47(47):1017-9.

9.

Ensuring preparedness for potential poliomyelitis outbreaks: Recommendations for the US poliovirus vaccine stockpile from the National Vaccine Advisory Committee (NVAC) and the Advisory Committee on Immunization Practices (ACIP).

Alexander L, Birkhead G, Guerra F, Helms C, Hinman A, Katz S, LeBaron CW, Modlin J, Murphy TV; National Vaccine Advisory Committee-Advisory Committee on Immunization Practices Joint Working Group; Centers for Disease Control and Prevention.

Arch Pediatr Adolesc Med. 2004 Dec;158(12):1106-12. Review.

PMID:
15583093
10.

Poliovirus vaccine options.

Zimmerman RK, Spann SJ.

Am Fam Physician. 1999 Jan 1;59(1):113-8, 125-6. Review.

12.

Introduction of inactivated poliovirus vaccine into oral poliovirus vaccine-using countries.

[No authors listed]

Wkly Epidemiol Rec. 2003 Jul 11;78(28):241-50. English, French.

PMID:
15571166
13.

Cost-effectiveness of incorporating inactivated poliovirus vaccine into the routine childhood immunization schedule.

Miller MA, Sutter RW, Strebel PM, Hadler SC.

JAMA. 1996 Sep 25;276(12):967-71.

PMID:
8805731
14.

A developing country perspective on vaccine-associated paralytic poliomyelitis.

John TJ.

Bull World Health Organ. 2004 Jan;82(1):53-7; discussion 57-8. Epub 2004 Feb 26.

16.

Epidemiology of poliomyelitis in the United States one decade after the last reported case of indigenous wild virus-associated disease.

Strebel PM, Sutter RW, Cochi SL, Biellik RJ, Brink EW, Kew OM, Pallansch MA, Orenstein WA, Hinman AR.

Clin Infect Dis. 1992 Feb;14(2):568-79. Review.

PMID:
1554844
17.

From the Centers for Disease Control and Prevention. Paralytic poliomyelitis--United States, 1980-1994.

[No authors listed]

JAMA. 1997 Feb 19;277(7):525-6. No abstract available.

PMID:
9032147
19.

World wide experience with inactivated poliovirus vaccine.

Bonnet MC, Dutta A.

Vaccine. 2008 Sep 15;26(39):4978-83. doi: 10.1016/j.vaccine.2008.07.026. Epub 2008 Aug 3. Review.

PMID:
18680777
20.

[End phase challenges of poliomyelitis eradication programme realization].

Jarzabek Z.

Przegl Epidemiol. 2005;59(1):59-68. Review. Polish.

PMID:
16013411
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk